Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O15126

Entry ID Method Resolution Chain Position Source
AF-O15126-F1 Predicted AlphaFoldDB

195 variants for O15126

Variant ID(s) Position Change Description Diseaes Association Provenance
CA360335896
rs1471229137
4 F>C No ClinGen
TOPMed
CA360335900
rs1443160433
5 D>Y No ClinGen
gnomAD
CA360335910
rs893362975
6 S>N No ClinGen
TOPMed
rs893362975
CA121631664
6 S>T No ClinGen
TOPMed
CA360335926
rs1483272772
8 P>R No ClinGen
TOPMed
gnomAD
CA121631665
rs867676205
10 A>V No ClinGen
Ensembl
CA360335942
rs966268989
11 D>H No ClinGen
TOPMed
gnomAD
CA121631666
rs966268989
11 D>N No ClinGen
TOPMed
gnomAD
rs542754511
CA121631668
12 P>A No ClinGen
TOPMed
rs779428769
CA3317516
13 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA360335954
rs779428769
13 D>Y No ClinGen
ExAC
TOPMed
gnomAD
CA360335960
rs1476755848
14 L>I No ClinGen
TOPMed
gnomAD
rs1476755848
CA360335961
14 L>V No ClinGen
TOPMed
gnomAD
CA3317517
rs748872971
15 N>S No ClinGen
ExAC
gnomAD
rs768070835
CA3317518
16 N>S No ClinGen
ExAC
gnomAD
rs1328918640
CA360335980
17 P>T No ClinGen
gnomAD
rs1477915991
CA360336287
20 D>G No ClinGen
gnomAD
CA360336307
rs1205344099
23 V>A No ClinGen
TOPMed
CA360336312
rs1375109843
24 T>I No ClinGen
TOPMed
gnomAD
rs1456757826
CA360336319
25 Q>R No ClinGen
gnomAD
CA360336328
TCGA novel
rs1163177915
26 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
TCGA novel 28 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1392169308
CA360336342
29 N>H No ClinGen
gnomAD
CA360336360
rs1296359668
31 P>L No ClinGen
gnomAD
CA3317543
rs771222877
31 P>T No ClinGen
ExAC
gnomAD
rs759682299
CA3317545
35 D>E No ClinGen
ExAC
gnomAD
CA3317546
rs765304173
37 Y>C No ClinGen
ExAC
gnomAD
CA3317547
rs775773775
41 S>L No ClinGen
ExAC
gnomAD
CA360336442
rs1214388599
44 R>G No ClinGen
gnomAD
TCGA novel 44 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767605406
CA3317549
45 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA360337432
rs1446870154
48 P>L No ClinGen
gnomAD
rs1244090530
CA360337429
48 P>S No ClinGen
gnomAD
rs75278293
CA3317570
50 G>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 50 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA360337444
rs1440849482
51 V>M No ClinGen
gnomAD
rs766180996
CA3317571
53 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs753642589
CA3317572
54 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs754625657
CA3317573
55 N>D No ClinGen
ExAC
gnomAD
rs754625657
CA360337471
55 N>H No ClinGen
ExAC
gnomAD
CA360337483
rs1409836200
56 V>G No ClinGen
TOPMed
gnomAD
CA360337488
rs1267492166
57 P>R No ClinGen
TOPMed
CA360337486
rs1303683982
57 P>S No ClinGen
gnomAD
rs764918144
CA3317574
58 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA360337514
rs1346875908
61 P>R No ClinGen
TOPMed
CA121637738
rs899032597
61 P>T No ClinGen
Ensembl
CA360337522
rs1330588709
63 I>V No ClinGen
gnomAD
rs752367944
CA3317575
69 E>K No ClinGen
ExAC
gnomAD
rs1272807127
CA360337582
71 P>T No ClinGen
TOPMed
CA3317576
rs757864357
72 A>S No ClinGen
ExAC
gnomAD
CA360337587
rs757864357
72 A>T No ClinGen
ExAC
gnomAD
rs1233486060
CA360337618
76 I>T No ClinGen
gnomAD
CA360337661
rs1170278796
80 H>Q No ClinGen
gnomAD
rs562453126
CA3317593
80 H>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3317596
rs762607304
86 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA360337702
rs1580677796
87 L>I No ClinGen
Ensembl
rs563016417
CA121637808
90 R>C No ClinGen
TOPMed
gnomAD
CA3317597
rs763582841
90 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA360337730
rs1580677810
91 Q>R No ClinGen
Ensembl
rs751098492
CA3317598
92 E>G No ClinGen
ExAC
gnomAD
rs751098492
CA360337738
92 E>V No ClinGen
ExAC
gnomAD
TCGA novel 93 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1337815041
CA360337753
94 L>P No ClinGen
gnomAD
CA3317599
rs376446901
95 E>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3317600
rs781601107
96 R>G No ClinGen
ExAC
gnomAD
CA360337766
rs1253126016
96 R>S No ClinGen
TOPMed
CA121637810
rs1040513272
97 K>R No ClinGen
TOPMed
gnomAD
CA121637811
rs867897885
98 A>D No ClinGen
Ensembl
CA360337780
rs762983897
99 A>S No ClinGen
gnomAD
CA121637812
rs762983897
99 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 101 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA360337801
rs1321584648
102 D>Y No ClinGen
gnomAD
rs369702031
CA3317602
103 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs181180317
CA121637813
103 R>H No ClinGen
1000Genomes
ExAC
gnomAD
CA3317603
rs181180317
103 R>P No ClinGen
1000Genomes
ExAC
gnomAD
rs1053225677
CA121637815
104 R>Q No ClinGen
TOPMed
rs186921534
CA121637814
104 R>W No ClinGen
1000Genomes
TOPMed
gnomAD
CA121637816
rs902907367
106 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs998531808
CA121637817
110 N>H No ClinGen
Ensembl
rs749503378
CA3317604
111 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs1354791577
CA360337882
114 H>R No ClinGen
TOPMed
rs1463057994
CA360337901
115 G>D No ClinGen
TOPMed
rs1170509518
CA360337906
116 R>K No ClinGen
TOPMed
rs761184019
CA3317619
122 P>L No ClinGen
ExAC
gnomAD
CA121638021
rs766168946
122 P>T No ClinGen
Ensembl
CA121638022
rs1035570204
126 N>S No ClinGen
Ensembl
CA3317621
CA3317622
rs750834214
130 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
TOPMed
gnomAD
NCI-TCGA
rs1251489713
CA360338031
134 Y>C No ClinGen
TOPMed
CA121638023
rs1060311
136 D>E No ClinGen
gnomAD
rs1408912356
CA360338043
136 D>N No ClinGen
gnomAD
CA121638024
rs904513207
139 V>A No ClinGen
TOPMed
gnomAD
rs754291847
CA3317624
141 I>V No ClinGen
ExAC
gnomAD
TCGA novel 143 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755227122
CA3317625
144 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs1217713171
CA360338125
147 K>N No ClinGen
TOPMed
gnomAD
rs937633735
CA121638025
148 T>S No ClinGen
TOPMed
CA360338138
rs1278110197
150 K>E No ClinGen
gnomAD
rs571110143
CA121638026
150 K>R No ClinGen
1000Genomes
rs748433715
CA3317627
151 L>I No ClinGen
ExAC
gnomAD
TCGA novel 151 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3317628
rs758343285
152 M>L No ClinGen
ExAC
gnomAD
TCGA novel 155 L>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA360338186
rs777923800
156 W>* No ClinGen
ExAC
TOPMed
gnomAD
CA3317629
rs777923800
156 W>C No ClinGen
ExAC
TOPMed
gnomAD
rs772841578
CA3317639
159 H>Y No ClinGen
ExAC
gnomAD
CA3317642
rs754416506
167 I>T No ClinGen
ExAC
gnomAD
CA360338276
rs1426052599
168 F>V No ClinGen
TOPMed
rs546816103
CA3317644
169 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1404081113
CA360338313
173 W>S No ClinGen
gnomAD
rs1302682989
CA360338328
175 C>F No ClinGen
gnomAD
rs758704780
CA3317646
176 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA360338348
rs1580681855
178 S>P No ClinGen
Ensembl
CA3317648
rs747133518
181 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3317650
rs779920399
188 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1224964292
CA360338463
195 T>A No ClinGen
TOPMed
TCGA novel 195 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA360338496
rs1255427818
200 V>I No ClinGen
gnomAD
CA360338506
rs749258929
201 C>F No ClinGen
ExAC
TOPMed
rs749258929
CA3317651
201 C>Y No ClinGen
ExAC
TOPMed
rs1221617649
CA360338538
205 P>L No ClinGen
TOPMed
gnomAD
rs747747383
CA3317654
206 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1309043987
CA360338566
210 F>V No ClinGen
TOPMed
rs759958028
CA3317698
212 S>G No ClinGen
ExAC
CA3317699
rs770374938
212 S>N No ClinGen
ExAC
gnomAD
rs775697616
CA3317700
212 S>R No ClinGen
ExAC
CA3317701
rs763330844
213 D>Y No ClinGen
ExAC
CA3317702
rs764476576
214 S>I No ClinGen
ExAC
CA3317703
rs751717405
215 S>* No ClinGen
ExAC
rs1237841667
CA360334642
220 V>I No ClinGen
TOPMed
gnomAD
rs1237841667
CA360334647
220 V>L Variant assessed as Somatic; 5.003e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs373924048
CA3317706
224 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368063973
CA3317707
225 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel
rs1580705122
CA360334731
226 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
Ensembl
CA360334795
rs1580705131
230 A>S No ClinGen
Ensembl
rs754845409
CA3317708
230 A>V No ClinGen
ExAC
gnomAD
rs1463084957
CA360334810
231 V>A No ClinGen
gnomAD
CA3317709
rs778858276
231 V>L No ClinGen
ExAC
gnomAD
CA360334862
rs1175953128
236 A>P No ClinGen
gnomAD
rs1175953128
CA360334863
236 A>S No ClinGen
gnomAD
rs1249942428
CA360334867
237 A>T No ClinGen
gnomAD
CA3317710
rs752605913
237 A>V No ClinGen
ExAC
gnomAD
CA360334882
rs1376206033
239 F>S No ClinGen
gnomAD
CA360334888
rs1469471279
240 H>Y No ClinGen
gnomAD
CA360334896
rs1176951017
241 N>D No ClinGen
gnomAD
CA121641838
rs112784381
244 N>K No ClinGen
gnomAD
CA360334920
rs1432904013
244 N>S No ClinGen
TOPMed
rs201591781
CA121641840
245 C>F No ClinGen
Ensembl
CA3317739
rs779447245
248 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1490192532
CA360336059
252 T>I No ClinGen
gnomAD
rs377285944
CA121642884
255 N>H No ClinGen
ESP
TOPMed
gnomAD
CA3317743
rs369489512
255 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772454258
CA3317744
256 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs1430274486
CA360336102
259 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA121642885
rs780757569
262 I>L No ClinGen
gnomAD
CA360336118
rs780757569
262 I>V No ClinGen
gnomAD
CA3317745
rs773415296
263 M>V No ClinGen
ExAC
gnomAD
CA121642886
rs948181674
264 M>T No ClinGen
Ensembl
rs1202884028
CA360336146
265 I>M No ClinGen
TOPMed
CA360336148
rs1364424447
266 I>V No ClinGen
gnomAD
CA360336167
rs1304429380
269 A>T No ClinGen
gnomAD
CA3317746
rs760819639
269 A>V No ClinGen
ExAC
gnomAD
CA360336192
rs1288697696
273 A>T No ClinGen
gnomAD
CA360336202
rs1363043974
274 S>* No ClinGen
gnomAD
CA3317748
rs776642657
275 A>V No ClinGen
ExAC
gnomAD
rs762952835
CA3317749
277 I>V No ClinGen
ExAC
gnomAD
rs1561286361
CA360336228
279 L>V No ClinGen
Ensembl
CA360336234
rs1327956377
280 V>I No ClinGen
TOPMed
CA3317751
rs560949259
281 M>I No ClinGen
1000Genomes
ExAC
gnomAD
CA360336242
rs1246887768
281 M>T No ClinGen
TOPMed
gnomAD
CA360336239
rs1358821363
281 M>V No ClinGen
gnomAD
CA360336251
rs1445542314
282 F>C No ClinGen
TOPMed
gnomAD
rs1321140383
CA360336256
283 K>E No ClinGen
TOPMed
CA121642887
rs565328695
284 K>E No ClinGen
TOPMed
gnomAD
rs759640596
CA3317768
290 R>G No ClinGen
ExAC
TOPMed
CA360336508
rs1334067745
291 T>K No ClinGen
gnomAD
rs1166936641
CA360336547
297 E>Q No ClinGen
Ensembl
CA121644775
rs768484867
302 E>K No ClinGen
Ensembl
rs982547144
CA121644777
305 T>K No ClinGen
Ensembl
CA360336609
rs1221883149
306 G>S No ClinGen
gnomAD
CA3317769
rs765441111
310 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA3317771
rs761858947
314 Q>H No ClinGen
ExAC
gnomAD
rs1580725941
CA360336674
315 T>I No ClinGen
Ensembl
CA3317773
rs750255612
316 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs760349410
CA3317774
318 A>T No ClinGen
ExAC
gnomAD
rs1234088647
CA360336703
320 A>E No ClinGen
gnomAD
rs1436942438
CA360336713
322 S>P No ClinGen
TOPMed
TCGA novel 323 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1580725959
CA360336730
325 A>T No ClinGen
Ensembl
CA360336745
rs1362779711
327 S>T No ClinGen
TOPMed
CA360336794
rs1198186085
334 K>E No ClinGen
gnomAD
rs765895805
CA3317775
334 K>M No ClinGen
ExAC
gnomAD
CA360336799
rs1470470531
335 G>S No ClinGen
gnomAD
rs1448745591
CA360336820
337 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA360336824
rs1174679203
338 I>T No ClinGen
gnomAD
rs200049902
CA121644778
338 I>V No ClinGen
TOPMed

No associated diseases with O15126

No regional properties for O15126

Type Name Position InterPro Accession
No domain, repeats, and functional sites for O15126

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus, trans-Golgi network membrane ; Multi-pass membrane protein
  • Recycling endosome membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
clathrin-coated vesicle A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of synaptic vesicle membrane The component of the synaptic vesicle membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
recycling endosome membrane The lipid bilayer surrounding a recycling endosome.
specific granule membrane The lipid bilayer surrounding a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.
trans-Golgi network The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
trans-Golgi network membrane The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network.
zymogen granule membrane The lipid bilayer surrounding a zymogen granule.

1 GO annotations of molecular function

Name Definition
protein domain specific binding Binding to a specific domain of a protein.

5 GO annotations of biological process

Name Definition
endocytosis A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
establishment of localization in cell Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation.
exocytosis A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
post-Golgi vesicle-mediated transport The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q969E2 SCAMP4 Secretory carrier-associated membrane protein 4 Homo sapiens (Human) PR
Q8K021 Scamp1 Secretory carrier-associated membrane protein 1 Mus musculus (Mouse) PR
Q9LR68 SCAMP2 Secretory carrier-associated membrane protein 2 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MSDFDSNPFA DPDLNNPFKD PSVTQVTRNV PPGLDEYNPF SDSRTPPPGG VKMPNVPNTQ
70 80 90 100 110 120
PAIMKPTEEH PAYTQIAKEH ALAQAELLKR QEELERKAAE LDRREREMQN LSQHGRKNNW
130 140 150 160 170 180
PPLPSNFPVG PCFYQDFSVD IPVEFQKTVK LMYYLWMFHA VTLFLNIFGC LAWFCVDSAR
190 200 210 220 230 240
AVDFGLSILW FLLFTPCSFV CWYRPLYGAF RSDSSFRFFV FFFVYICQFA VHVLQAAGFH
250 260 270 280 290 300
NWGNCGWISS LTGLNQNIPV GIMMIIIAAL FTASAVISLV MFKKVHGLYR TTGASFEKAQ
310 320 330
QEFATGVMSN KTVQTAAANA ASTAASSAAQ NAFKGNQI